D3Penta 21 clinical trial design A randomised noninferiority trial with nested drug licensing substudy to assess dolutegravir and lamivudine fixed dose formulations for the maintenance of virological suppression in children with HIV1 infection aged 2

A TurkovaM ChanC KityoA KekitiinwaE et alAvyi ViolariEbrahim Variava2025-04-06WOS1551-7144https://hdl.handle.net/10539/44594D3Penta 21 clinical trial design A randomised noninferiority trial with nested drug licensing substudy to assess dolutegravir and lamivudine fixed dose formulations for the maintenance of virological suppression in children with HIV1 infection aged 2Journal Article